Westlake Chemical Corporation 8-K Summary
Business Context and Reporting Period
Westlake Chemical Corporation (Westlake) filed a Current Report on Form 8-K dated July 17, 2014. The filing reports the entry into a Material Definitive Agreement involving a third amendment and restatement of the Company's Second Amended and Restated Credit Agreement.
Key Financial Metrics and Debt Structure
The filing details a $400 million senior secured revolving credit facility. Key terms include:
- Facility Size: $400 million total commitment.
- Maturity Date: Extended from September 16, 2016, to July 17, 2019.
- Interest Rates: LIBOR plus a spread of 1.25% to 1.75% (capped at 1.50% if investment grade) or Base Rate plus 0.00% to 0.50%.
- Unused Commitment Fee: 0.25%.
- Letters of Credit: $400 million sub-limit.
- Borrowing Base: Limited to 85% of eligible accounts receivable, plus the lesser of 70% of inventory value or 85% of appraised net orderly liquidation value, plus 100% of controlled cash.
- Expansion Option: Borrowers may increase the facility up to four times in increments of at least $25 million (maximum $200 million) subject to lender agreement.
The filing does not provide specific values for revenue, profit, cash flow, or current liquidity positions.
Material Changes and Covenants
The Amendment and Restatement introduced several material changes to the credit agreement:
- Cost Reduction: Reduced interest rates and facility fees.
- Fixed Charge Coverage Ratio (FCCR): Requires a minimum FCCR of 1.0:1.0 for successive 30-day periods if borrowing availability falls below the greater of 10% of commitments or $40 million.
- Distribution Restrictions: Generally restricts distributions unless borrowing availability exceeds the greater of 20% of commitments or $80 million (or 15%/$60 million with a 1.0:1.0 FCCR). An exception allows aggregate distributions of up to $75 million, increasing by 5% annually thereafter.
- Acquisition and Investment Restrictions: Generally restricts M&A unless borrowing availability exceeds the greater of 15% of commitments or $60 million (or 12.5%/$50 million with a 1.0:1.0 FCCR). Exceptions allow investments up to the greater of $50 million or 1.25% of tangible assets, and acquisitions up to the greater of $100 million or 2.5% of tangible assets.
- Debt Incurrence: Permits up to the greater of $300 million or 7.5% of tangible assets in purchase money debt and unlimited debt secured by non-collateral assets.
- MLP Transaction: Explicitly permits transactions related to the initial public offering of Westlake Chemical Partners LP.
Guidance, Outlook, and Risks
The filing does not contain forward-looking guidance, management commentary on operational outlook, or specific risk factors beyond the covenants inherent in the credit agreement. The primary contingency noted is the requirement to maintain specific borrowing availability and coverage ratios to execute distributions or acquisitions.
Key Facts for Investor Verification
- Verify the Company's current borrowing availability against the new covenant thresholds (10%/$40 million for FCCR triggers; 20%/$80 million for distributions).
- Confirm the Company's current credit rating to determine if the LIBOR spread is capped at 1.50%.
- Review the impact of the $75 million annual distribution allowance on shareholder returns versus the stricter availability-based covenants.
- Assess the Company's tangible asset base to calculate the specific dollar limits for permitted acquisitions and investments.
- Monitor the status of the Westlake Chemical Partners LP IPO referenced in the agreement.